slow off the mark, page-3

The important thing for me is Amgen has shown themselves to be quite clever in their approach to getting new devices to the market. They are certainly one of the early adopters of improved device technologies from various suppliers.

UNS is now one of them and given that they are open to acquiring shares in the company that means we can become their defacto device supplier. So IMPORTANTLY for me this sure helps short term cash receipts etc but most importantly it is a pharma so that means more drugs in our devices without the painfully slow heavy lifting UNS has had to do the past few years